Sign Up

About ARALAST NP Therapy

ARALAST NP ARALAST NP

Alpha-1 as Seen on PBS

You will need Macromedia Flash Player 8 or higher to view the video.

Baxter is proud to be a sponsor of Alpha-1 Antitrypsin Deficiency: The Disease that Can Destroy the Lungs, part of the award-winning Healthy Body Healthy Mind series as seen on PBS.

  • Meet four interesting people who are living with Alpha-1 and hear their stories about diagnosis, treatment and lifestyle choices.
  • Learn from a noted pulmonologist about the genetics of Alpha-1 and why family testing is so important.
  • Find out how the new GINA bill protects you and your family from discrimination.

ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]

ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.

The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.

Please review the Important Risk Information and the Full Prescribing Information

Please review the Important Risk Information and the Full Prescribing Information